Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaella Giavazzi

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 19, 2016
Orthotopic Model of Ovarian CancerAlessandra Decio, Raffaella Giavazzi
Methods in Molecular Biology (Clifton, N.J.)|October 5, 2013
Syngeneic murine metastasis models: B16 melanomaRaffaella Giavazzi, Alessandra Decio
Thrombosis Research|April 29, 2018
Anti-angiogenesis for cancer: Current status and prospectsMassimo Russo, Raffaella Giavazzi
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Small molecules in anti-angiogenic therapyRaffaella Giavazzi, Maria Ines Nicoletti
Cancer Metastasis Reviews|September 27, 2007
Tumor-host interaction in the optimization of paclitaxel-based combination therapies with vascular targeting compoundsRaffaella Giavazzi, Maria Rosa Bani, Giulia Taraboletti
Anti-Cancer Drugs|April 8, 2003
IDN 5390: a new concept in taxane developmentGiulia Taraboletti, Gianluca Micheletti, Raffaella Giavazzi, et al.
Angiogenesis|April 9, 2017
Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonistsMariaRosa Bani, Alessandra Decio, Raffaella Giavazzi, et al.
Frontiers in Oncology|October 9, 2013
Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agentsMarta Cesca, Francesca Bizzaro, Massimo Zucchetti, et al.
Chinese Journal of Cancer|July 1, 2016
Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamicsIlaria Fuso Nerini, Marta Cesca, Francesca Bizzaro, et al.
The International Journal of Biochemistry & Cell Biology|August 26, 2011
Targeting angiogenesis with compounds from the extracellular matrixDorina Belotti, Chiara Foglieni, Andrea Resovi, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Methods in Molecular Biology (Clifton, N.J.)|November 19, 2016
Orthotopic Model of Ovarian CancerAlessandra Decio, Raffaella Giavazzi
Methods in Molecular Biology (Clifton, N.J.)|October 5, 2013
Syngeneic murine metastasis models: B16 melanomaRaffaella Giavazzi, Alessandra Decio
Thrombosis Research|April 29, 2018
Anti-angiogenesis for cancer: Current status and prospectsMassimo Russo, Raffaella Giavazzi
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Small molecules in anti-angiogenic therapyRaffaella Giavazzi, Maria Ines Nicoletti
Cancer Metastasis Reviews|September 27, 2007
Tumor-host interaction in the optimization of paclitaxel-based combination therapies with vascular targeting compoundsRaffaella Giavazzi, Maria Rosa Bani, Giulia Taraboletti
Anti-Cancer Drugs|April 8, 2003
IDN 5390: a new concept in taxane developmentGiulia Taraboletti, Gianluca Micheletti, Raffaella Giavazzi, et al.
Angiogenesis|April 9, 2017
Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonistsMariaRosa Bani, Alessandra Decio, Raffaella Giavazzi, et al.
Frontiers in Oncology|October 9, 2013
Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agentsMarta Cesca, Francesca Bizzaro, Massimo Zucchetti, et al.
Chinese Journal of Cancer|July 1, 2016
Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamicsIlaria Fuso Nerini, Marta Cesca, Francesca Bizzaro, et al.
The International Journal of Biochemistry & Cell Biology|August 26, 2011
Targeting angiogenesis with compounds from the extracellular matrixDorina Belotti, Chiara Foglieni, Andrea Resovi, et al.
Pageof 10